1. Home
  2. PKST vs RVPHW Comparison

PKST vs RVPHW Comparison

Compare PKST & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PKST
  • RVPHW
  • Stock Information
  • Founded
  • PKST 2008
  • RVPHW 2018
  • Country
  • PKST United States
  • RVPHW United States
  • Employees
  • PKST 38
  • RVPHW 14
  • Industry
  • PKST Real Estate Investment Trusts
  • RVPHW Biotechnology: Pharmaceutical Preparations
  • Sector
  • PKST Real Estate
  • RVPHW Health Care
  • Exchange
  • PKST Nasdaq
  • RVPHW Nasdaq
  • Market Cap
  • PKST 419.1M
  • RVPHW N/A
  • IPO Year
  • PKST N/A
  • RVPHW N/A
  • Fundamental
  • Price
  • PKST $11.22
  • RVPHW $0.06
  • Analyst Decision
  • PKST Buy
  • RVPHW
  • Analyst Count
  • PKST 2
  • RVPHW 0
  • Target Price
  • PKST $15.00
  • RVPHW N/A
  • AVG Volume (30 Days)
  • PKST 130.3K
  • RVPHW 22.4K
  • Earning Date
  • PKST 05-08-2025
  • RVPHW 03-14-2025
  • Dividend Yield
  • PKST 7.97%
  • RVPHW N/A
  • EPS Growth
  • PKST N/A
  • RVPHW N/A
  • EPS
  • PKST N/A
  • RVPHW N/A
  • Revenue
  • PKST $228,073,000.00
  • RVPHW N/A
  • Revenue This Year
  • PKST N/A
  • RVPHW N/A
  • Revenue Next Year
  • PKST N/A
  • RVPHW N/A
  • P/E Ratio
  • PKST N/A
  • RVPHW N/A
  • Revenue Growth
  • PKST 10.26
  • RVPHW N/A
  • 52 Week Low
  • PKST $9.89
  • RVPHW $0.13
  • 52 Week High
  • PKST $16.26
  • RVPHW $0.15
  • Technical
  • Relative Strength Index (RSI)
  • PKST 38.37
  • RVPHW N/A
  • Support Level
  • PKST $11.07
  • RVPHW N/A
  • Resistance Level
  • PKST $11.68
  • RVPHW N/A
  • Average True Range (ATR)
  • PKST 0.46
  • RVPHW 0.00
  • MACD
  • PKST -0.08
  • RVPHW 0.00
  • Stochastic Oscillator
  • PKST 5.01
  • RVPHW 0.00

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: